Impact of aging on cancer immunity and immunotherapy.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 11
Results: 18
1
2
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
3
Dynamic changes of interleukin-8 network along the colorectal adenoma–carcinoma sequence.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1899, doi. 10.1007/s00262-009-0702-y
- By:
- Publication type:
- Article
4
Breast tumor cells isolated from in vitro resistance to trastuzumab remain sensitive to trastuzumab anti-tumor effects in vivo and to ADCC killing.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1889, doi. 10.1007/s00262-009-0700-0
- By:
- Publication type:
- Article
5
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1879, doi. 10.1007/s00262-009-0699-2
- By:
- Publication type:
- Article
6
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1821, doi. 10.1007/s00262-009-0693-8
- By:
- Publication type:
- Article
7
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1855, doi. 10.1007/s00262-009-0697-4
- By:
- Publication type:
- Article
8
Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1833, doi. 10.1007/s00262-009-0694-7
- By:
- Publication type:
- Article
9
Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1867, doi. 10.1007/s00262-009-0698-3
- By:
- Publication type:
- Article
10
Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1845, doi. 10.1007/s00262-009-0695-6
- By:
- Publication type:
- Article
11
Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1803, doi. 10.1007/s00262-009-0691-x
- By:
- Publication type:
- Article
12
Onconeural antibodies in sera from patients with various types of tumours.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1797, doi. 10.1007/s00262-009-0690-y
- By:
- Publication type:
- Article
13
TGF-β modulates the functionality of tumor-infiltrating CD8<sup>+</sup> T cells through effects on TCR signaling and Spred1 expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1811, doi. 10.1007/s00262-009-0692-9
- By:
- Publication type:
- Article
14
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1773, doi. 10.1007/s00262-009-0685-8
- By:
- Publication type:
- Article
15
Improvement of tumor targeting and antitumor activity by a disulphide bond stabilized diabody expressed in Escherichia coli.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1763, doi. 10.1007/s00262-009-0684-9
- By:
- Publication type:
- Article
16
Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1783, doi. 10.1007/s00262-009-0689-4
- By:
- Publication type:
- Article
17
Treatment combinations targeting apoptosis to improve immunotherapy of melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1751, doi. 10.1007/s00262-009-0732-5
- By:
- Publication type:
- Article
18
On the origin of serum CD26 and its altered concentration in cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1725, doi. 10.1007/s00262-009-0728-1
- By:
- Publication type:
- Article